-
Mashup Score: 1MYBL2 Drives Prostate Cancer Plasticity - OncoDaily - 6 month(s) ago
MYBL2 Drives Prostate Cancer Plasticity / Anjali V. Sheahan, Beatriz German, cancer, Cancer Research Communications, Deborah L Burkhart, Ellis Lab, Hannah E.
Source: oncodaily.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 47MYBL2 Drives Prostate Cancer Plasticity: Inhibiting its Transcriptional Target CDK2 for RB1-Deficient Neuroendocrine Prostate Cancer - PubMed - 6 month(s) ago
Phenotypic plasticity is a recognized mechanism driving therapeutic resistance in prostate cancer (PCa) patients. While underlying molecular causations driving phenotypic plasticity have been identified, therapeutic success is yet to be achieved. To identify putative master regulator transcription f …
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet-
What to go over a smaller paper just out from the lab in @CRC_AACR https://t.co/TjyIKGT99Z Thanks to all involved and to first author @BeatrizGerFalc for bringing this home. Some major points below
-
-
Mashup Score: 3The Nobel Prize on LinkedIn: Less than 100 years ago, prostate cancer which attacks a gland that is… | 12 comments - 7 month(s) ago
Less than 100 years ago, prostate cancer which attacks a gland that is part of the male sex organ, was seen as a death sentence because so little was known… | 12 comments on LinkedIn
Source: www.linkedin.comCategories: General Medicine News, Hem/OncsTweet-
Needed a bit of a boost today and this got posted #timing https://t.co/02vYUmy3Jf
-
-
Mashup Score: 13The official website of the Nobel Prize - NobelPrize.org - 7 month(s) ago
“When I meet patients who tell me: ‘You saved my life,’ it is an unforgettable moment.” Read about laureates James P. Allison and Tasuku Honjo and their discovery of a new cancer therapy. The first woman to be awarded a Nobel Prize, the first individual to be awarded two Nobel Prizes and still today the only individual with two Nobel Prizes in two different scientific categories is Marie Skłodowska Curie. She developed the term radioactivity, discovered the chemical elements polonium and radium and
Source: www.nobelprize.orgCategories: General Medicine News, Hem/OncsTweet-
Charles B. Huggins – Biographical - https://t.co/9WhuksFyg7 https://t.co/40KtVJC72N
-
-
Mashup Score: 5
Ependymomas are common childhood brain tumours that occur throughout the nervous system, but are most common in the paediatric hindbrain. Current standard therapy comprises surgery and radiation, but not cytotoxic chemotherapy as it does not further increase survival. Whole-genome and whole-exome se …
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet-
RT @MatLupien: 10 years after discovering the first cancer arising from chromatin as opposed to genetic variants (https://t.co/tegI4AoJFw)…
-
-
Mashup Score: 17Nurse Practitioner I - Center for Prostate Disease Research in Bethesda, Maryland | Careers at WRNMMC - 11 month(s) ago
Join the HJF Team! HJF is seeking a Nurse Practitioner I to support the Murtha Cancer Center Research Program’s (MCCRP) Center for Prostate Disease Research (CPDR), located at the Walter Reed National Military Medical Center (WRNMMC) in Bethesda, MD. The Nurse Practitioner helps with all aspects of patient care for prostate disease and cancer, including diagnosis, treatments and consultations. May work in outpatient and research situations and performs independently or as part of a treatment team. Educates patients about preventative care and prescribed treatments. Conduct physical exams, orders tests and medications, and serves as a patient’s primary healthcare provider. Note: This position requires U.S. Citizenship. About CPDR: CPDR is an interdisciplinary translational prostate cancer research program of the Uniformed Services University of the Health Sciences (USUHS) Department of Surgery and the John P. Murtha Cancer Center Research Program at the Walter Reed National Milita
Source: careers-hjf.icims.comCategories: General Medicine News, Hem/OncsTweet-
Our CPDR clinic is looking for a NP. Please apply or pass on to someone you may know. Thanks Nurse Practitioner I - Center for Prostate Disease Research in Bethesda, Maryland | Careers at WRNMMC https://t.co/kg468tQfAX
-
-
Mashup Score: 1
Nature Methods – We developed Significant Latent Factor Interaction Discovery and Exploration (SLIDE), an interpretable machine learning approach that can infer hidden states (latent factors)…
Source: www.nature.comCategories: General Medicine News, Hem/OncsTweet-
RT @juhyunk_: Uncovering hidden states driving biological outcomes using machine learning https://t.co/o4kkxHkyQH #journals #feedly
-
-
Mashup Score: 3John Rasko AO on LinkedIn: One of Australia’s greatest biomedical research scientists was honored… - 1 year(s) ago
One of Australia’s greatest biomedical research scientists was honored today by giving the Ashley Dunn Oration at the Lorne Cancer conference – Professor…
Source: www.linkedin.comCategories: General Medicine News, Hem/OncsTweet-
https://t.co/e9NWAsuIYO
-
-
Mashup Score: 38Single-cell and spatial profiling identify three response trajectories to pembrolizumab and radiation therapy in triple negative breast cancer - 1 year(s) ago
Shiao et al. reveals the phenotypic and spatial changes that occur in the tumor immune microenvironment following anti-PD-1 therapy and radiation in triple-negative breast cancer. They identify three spatial distributions that associate with early responders, late responders and non-responders.
Source: www.cell.comCategories: General Medicine News, Hem/OncsTweet-
Fantastic work from #SimonKnott #StephenShiao @CSCancerCenter Single-cell and spatial profiling identify three response trajectories to pembrolizumab and radiation therapy in triple negative breast cancer: Cancer Cell https://t.co/Smo14TxOon
-
-
Mashup Score: 38Single-cell and spatial profiling identify three response trajectories to pembrolizumab and radiation therapy in triple negative breast cancer - 1 year(s) ago
Shiao et al. reveals the phenotypic and spatial changes that occur in the tumor immune microenvironment following anti-PD-1 therapy and radiation in triple-negative breast cancer. They identify three spatial distributions that associate with early responders, late responders and non-responders.
Source: www.cell.comCategories: General Medicine News, Hem/OncsTweet-
Fantastic work from #SimonKnott #StephenShiao @CSCancerCenter Single-cell and spatial profiling identify three response trajectories to pembrolizumab and radiation therapy in triple negative breast cancer: Cancer Cell https://t.co/Smo14TxOon
-
RT @oncodaily: MYBL2 Drives Prostate Cancer Plasticity https://t.co/k79ZvNlTOs @CRC_AACR @EllisLab_ @BeatrizGerFalc @sarahaboualaiwi @K…